80
Participants
Start Date
March 31, 2025
Primary Completion Date
September 13, 2026
Study Completion Date
December 31, 2026
After surgery for Crohn's disease, eligible patients will be randomized 1:1 to receive oral EXL01 or placebo with or without SoC treatment (based on investigator decision) for up to 24 weeks
Randomisation will be stratified on post-surgical treatment (none vs anti-TNF), and on smoking status (non-smoker vs smoker).
RECRUITING
CHU Saint Louis, Paris
RECRUITING
Hôpital Saint Antoine, Paris
RECRUITING
Hôpital Bicêtre, Le Kremlin-Bicêtre
RECRUITING
CHU Clermont-Ferrand, Clermont-Ferrand
RECRUITING
Hôpital Henri Mondor, Créteil
RECRUITING
CHU Lille, Lille
RECRUITING
Hospices civils Lyon Sud, Lyon
RECRUITING
CHU Marseille Nord, Marseille
RECRUITING
CHU Montpellier, Montpellier
RECRUITING
CHU Nancy, Nancy
RECRUITING
CHU Nantes, Nantes
RECRUITING
CHU Nice Archet 2, Nice
Madeleine Bezault
OTHER